key: cord-0426052-zww9s31w
authors: Schuster, B.A.; Sowden, S.; Rybicki, A.J.; Fraser, D.S.; Press, C.; Holland, P.; Cook, J.L.
title: Dopaminergic modulation of dynamic emotion perception
date: 2022-03-04
journal: bioRxiv
DOI: 10.1101/2022.03.02.482469
sha: f7f06822ebb5ba132ce4510784d888d94592751b
doc_id: 426052
cord_uid: zww9s31w

Emotion recognition abilities are fundamental to our everyday social interaction. A large number of clinical populations show impairments in this domain, with emotion recognition atypicalities being particularly prevalent among disorders exhibiting a dopamine system disruption (e.g., Parkinson’s disease). Although this suggests a role for dopamine in emotion recognition, studies employing dopamine manipulation in healthy volunteers have exhibited mixed neural findings and no behavioural modulation. Interestingly, whilst a dependence of dopaminergic drug effects on individual baseline dopamine function has been well established in other cognitive domains, the emotion recognition literature so far has failed to account for these possible interindividual differences. The present within-subjects study therefore tested the effects of the dopamine D2 antagonist haloperidol on emotion recognition from dynamic, whole-body stimuli while accounting for interindividual differences in baseline dopamine. 33 healthy male and female adults rated emotional point-light walkers (PLWs) once after ingestion of 2.5 mg haloperidol and once after placebo. To evaluate potential mechanistic pathways of the dopaminergic modulation of emotion recognition, participants also performed motoric and counting-based indices of temporal processing. Confirming our hypotheses, effects of haloperidol on emotion recognition depended on baseline dopamine function, where individuals with low baseline dopamine showed enhanced, and those with high baseline dopamine decreased emotion recognition. Drug effects on emotion recognition were related to drug effects on movement-based and explicit timing mechanisms, indicating possible mediating effects of temporal processing. Results highlight the need for future studies to account for baseline dopamine and suggest putative mechanisms underlying the dopaminergic modulation of emotion recognition. Significance statement A high prevalence of emotion recognition difficulties amongst clinical conditions where the dopamine system is affected suggests an involvement of dopamine in emotion recognition processes. However, previous psychopharmacological studies seeking to confirm this role in healthy volunteers thus far have failed to establish whether dopamine affects emotion recognition and lack mechanistic insights. The present study uncovered effects of dopamine on emotion recognition in healthy individuals by controlling for interindividual differences in baseline dopamine function and investigated potential mechanistic pathways via which dopamine may modulate emotion recognition. Our findings suggest that dopamine may influence emotion recognition via its effects on temporal processing, providing new directions for future research on typical and atypical emotion recognition.

The ability to recognize others' emotions from facial and bodily cues is an important 39 skill that facilitates the development of meaningful social relationships (Izard et al., 2001; 40 Wang et al., 2019) . However, the cues towards genuine expressions of emotions are often 41

subtle. When we are sad we do not pull a face that bears much resemblance to the Ekman 42 example, but rather subtly alter the particular spatiotemporal dynamics of the way we move 43 our body and face (e.g., Michalak 2007)) during emotion processing, they have typically 54 not found behavioral influences. One explanation for this mixed picture is that there is an 55 optimal level of dopamine for such tasks, and that -dependent upon one's baseline levels -56 dopaminergic modulation brings individuals closer to, or further away from, that optimum 57 memory span -which are found to comprise a good proxy (Cools et al., 2008; Landau et al., 64 2009 ). Such studies find that individuals with low working memory span -signaling low 65 dopamine synthesis capacity -exhibit different behavioral responses to a dopaminergic 66 modulation to those with higher span (capacity). 67

It is also notable that while a role for dopamine in emotion perception is suggested by 68 studies illustrating aberrations in clinical conditions with dopamine dysfunctions, we do not 69 have good mechanistic models of the nature of that role. Some plausible contenders could relate 70

to the influence of dopamine on temporal and motor encoding. Many of the cues signaling 71 emotional state are dynamic, and will therefore depend upon one's ability to encode temporal 72 features. For instance, whereas rapid, accelerated movements are associated with anger, slower 73 and sluggish movements tend to be interpreted as sadness (Gross et To examine the role played by dopamine in emotion recognition, this study presented 82 participants with a dynamic whole-body emotion recognition task under the dopamine D2 83 receptor antagonist haloperidol, and a placebo. We separated our analyses according to baseline 84 working memory span and examined whether influences of the drug were modulated by 85 performance in movement-and counting-based indices of temporal processing. 86 

Participants' eligibility for the study was evaluated by a clinician via review of their 102 medical history, electrocardiogram assessment and blood-pressure check. The main study took 103 place on two separate test days, one to four weeks apart, where participants first completed an 104 initial blood-pressure and blood-oxygenation check with the medic. Subsequently, in a double-105 blind, placebo controlled within-subjects design, each participant took part on two study days, 106 wherein all participants received tablets containing either 2.5 mg haloperidol or lactose 107 (placebo) on the first day, and the respective other treatment on the second day (order of drug 108 day counterbalanced). For this, participants were handed a pre-prepared envelope, instructed 109 that this would contain either placebo or haloperidol tablets, informed that none of the 110 experimenters knew the contents of the envelope, and asked to close their eyes before Reported mean values for peak concentration and elimination half-life of oral haloperidol 120 lie between 1.7 and 6.1 and 14.5 -36.7 hours, respectively (Kudo and Ishizaki, 1999) . After 121 drug administration, participants rested for 1.5 hours to allow for drug metabolization. 122 Subsequently participants began the task battery, which included the emotion recognition task, 123 a verbal working memory task and indices of drug effects on movement-and counting-based 124 temporal processing (see Method: Tasks and procedure). Throughout the day, participants' 125 blood -pressure and -oxygenation was checked hourly between tasks. All data was collected at 126 the Centre for Human Brain Health (CHBH) at the University of Birmingham, UK. 127 128 Tasks and procedure 129

Participants completed a task battery including tasks not described in this study. All 130 relevant tasks are described below in order of presentation. Task order was the same on both 131 study days. presentation of a fixation cross (duration varied between 500-1000 ms), a list of 5-9 characters was presented 163 for 1000 ms, followed by a blue fixation cross (3000 ms). characters in length, depending on the block; 1000 ms), followed by a blue fixation cross (3000 165 ms). A single test letter was then displayed (4000 ms), and participants were asked whether the 166 letter was taken from the previously displayed list (Fig. 1B) . Participants responded by pressing 167 1-3 on the keyboard (1 -Yes, 2 -No, 3 -Unsure). Responses (accuracy) and response time 168

(time from test letter displayed until participant response) were recorded for each trial. Each 169 block varied in length from 5-9 consonants, with letters randomly selected from the alphabet 170 on each trial. The total task duration was approximately 10 minutes and test trials were 171 preceded by 10 practice trials. On each trial, participants first viewed a fixation cross for 1000 ms, followed by a PLW 193

stimulus. Subsequently three separate visual-analogue scales (ranging from 1 [not at all] to 10 194

[very]) were presented one after another, in pseudorandom order, asking participants to rate 195 how intensely they felt the stimulus was expressing an angry, happy, or sad emotional state 196 (Fig. 1A) . 197 198 Walking task. Following the emotion recognition task (task order was fixed to avoid 199 priming effects of own speed on emotion judgements from PLWs' speeds; for more details see 

To confirm that individuals made use of the emotion-specific speed information when 259 rating PLW stimuli, and to ascertain that the drug did not affect particiants' sensitivity to the 260 

abilities under haloperidol. Note that the same pattern emerged when using a continuous 317 variable for WM span, hence for illustrative purposes (Fig. 2) low WM groups, slower movement speed under the drug was associated with increased 380 emotion recognition, however, haloperidol-induced slowing was observed only in the low WM 381 group (Fig. 3B) . artificially slowing one's movement pace in a particular setting (e.g., via haloperidol 438 administration) would be unlikely to re-anchor all models. Given these concerns, we did not 439 feel confident to make strong predictions about emotion-specific effects and we are, indeed, 440 unsurprised to see that this pattern was not reflected in the data. 441

An important question concerns why we would see such dramatically different results 442 in individuals with high versus low working memory. Interestingly, despite the absence of an 443 effect of haloperidol on movement speed in the high working memory span group, we 444 nevertheless observed that the drug impaired emotion recognition in this group. Thus, 445

suggesting that timing/movement-based effects are not the only mechanism by which 446 haloperidol can affect emotion recognition. One additional mechanism concerns haloperidol's 447 effects on the maintenance of mental representations. Biologically-inspired models (Frank et both pre-and post-synaptic effects. Since we used a slightly higher dose than Frank and 460 O'Reilly (2.5 mg, versus 2 mg) it is feasible that our low-span subjects obtained a high enough 461 dose of haloperidol that they experienced both pre-and post-synaptic effects, whereas our high-462 span subjects experienced only mild pre-synaptic effects. It would follow from this that our 463 low-span subjects should exhibit enhanced updating of rewarded/salient mental representations 464 (the pre-synaptic effect) and more stable representations in general that are robust against 465

interference from non-target information (the post-synaptic effect). In contrast, our high-span 466 participants should have only experienced the former (pre-synaptic) effect. 467

For accurate emotion recognition, in the context of our paradigm, one must maintain a 468 stable and robust representation of the target PLW (e.g., angry PLW), and resist replacing it 469 with a non-target representation (for example, an imagined PLW prompted by a sad or happy 470 rating scale). Thus, post-synaptic effects, which promote stable and robust mental 471 representations would benefit emotion recognition, resulting in the pattern (high target ratings 472 and low non-target ratings) we observed in our low-span group. In contrast, since pre-synaptic 

Facial emotion recognition in 504

Parkinson's disease: A review and new hypotheses

Random effects structure for confirmatory 506 hypothesis testing: Keep it maximal

Inhibition of Dopamine Release Via 509

Presynaptic D2 Receptors: Time Course and Functional Characteristics <em>In 510

Dopamine in motivational control: 512 rewarding, aversive, and alerting

brms: An R Package for Bayesian Multilevel Models Using Stan

Inverted-U-shaped dopamine actions on human working 516 memory and cognitive control

Working memory capacity 518 predicts dopamine synthesis capacity in the human striatum

Dopamine Precursor Depletion Impairs 521 Timing in Healthy Volunteers by Attenuating Activity in Putamen and Supplementary 522 Motor Area

How movements shape the 524 perception of time

Amygdala activation 526 modulated by levodopa during emotional recognition processing in healthy 527 volunteers: a double-blind, placebo-controlled study

Effect of levodopa 530 on healthy volunteers' facial emotion perception: an FMRI study

Dopamine, Prediction Error and Beyond

Association between action kinematics and 535 emotion perception across adolescence

Our own action kinematics predict the 538 perceived affective states of others

Emotion recognition via facial expression and 541 affective prosody in schizophrenia: a methodological review

Dynamic dopamine modulation in the basal ganglia: a neurocomputational 544 account of cognitive deficits in medicated and nonmedicated Parkinsonism

A mechanistic account of striatal dopamine function in human 547 cognition: psychopharmacological studies with cabergoline and haloperidol

Anatomy of a decision: striato-orbitofrontal interactions in 550 reinforcement learning, decision making, and reversal

Interactions between frontal cortex and basal 552 ganglia in working memory: A computational model. Cognitive, Affective, & 553 Behavioral Neuroscience

Bayesian regression modeling (for factorial designs): A tutorial

Individual capacity differences predict working memory 557 performance and prefrontal activity following dopamine receptor stimulation

Effort-Shape and kinematic assessment of 560 bodily expression of emotion during gait

Not all is noticed: Kinematic cues of emotion-specific gait

Dextroamphetamine Modulates the Response 564 of the Human Amygdala

Emotion 566 recognition in Huntington's disease: A systematic review

What are you doing? How active and observational 569 experience shape infants' action understanding

Emotion 572 knowledge as a predictor of social behavior and academic competence in children at 573 risk

Effects of bromocriptine on human subjects 575 depend on working memory capacity

Pharmacokinetics of Haloperidol

Striatal Dopamine and Working 579 Memory

Selective disruption of the 581 recognition of facial expressions of anger

MATLAB (2021) version R2021a

Effects of Dextroamphetamine on Cognitive Performance 585 and Cortical Activation

Embodiment of 587 Sadness and Depression-Gait Patterns Associated With Dysphoric Mood. 588 Psychosomatic Medicine 71

Recognizing Biological Motion and Emotions from Point-Light Displays in Autism 591 Spectrum Disorders

Bayesian Multilevel Models Using brms: A Case Study of Gender Effects on Vowel 594 Variability in Standard Indonesian

Inverse agonism at dopamine D2 596 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with 597 the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, 598 and phenoxybenzamine

Tonic dopamine: opportunity costs and the control 600 of response vigor

Making working memory work: a computational model of 602 learning in the prefrontal cortex and basal ganglia

Critical features for the perception of 604 emotion from gait

Effects of methylphenidate on 607 reinforcement learning depend on working memory capacity

Presynaptic regulation of 610 dopaminergic neurotransmission

The role of movement 612 kinematics in facial emotion expression production and recognition. Emotion:No 613 Pagination Specified-No Pagination Specified

High-speed scanning in human memory

Effects of 616 dopaminergic and serotonergic manipulation on emotional processing: a 617 pharmacological fMRI study

R: A language and environment for statistical 619 computing

The Role of Dopamine in 621 Temporal Uncertainty

Characteristics of Emotion 623 Recognition Ability among Primary School Children: Relationships with Peer Status 624 and Friendship Quality

Modulation of memory fields by dopamine Dl 626 receptors in prefrontal cortex

A) Depiction of one trial of PLW perception task. A fixation cross was 630 presented for 1000 ms and followed by a PLW stimulus

Not at all' to 'Very') in pseudorandom order how angry, happy, and sad they perceived 633 the PLW stimulus to be. (B) Depiction of one trial of visual working memory task

shaded areas surrounding boxes represent 1 SD above and below mean 638 values. (B-C) Emotion recognition difference scores represent the difference between 639 emotion recognition scores in haloperidol and placebo trials, where positive difference 640 scores indicate enhanced emotion recognition performance under haloperidol. The central 641 mark of each of the box plots below PDFs represents the median of each group, edges 642 represent 25 th (Q1) and 75 th (Q3) percentiles

Q1) above and Q1 + 1.5 x (Q3 -Q1) below box edges

A) Boxes represent 1 SEM above and below the mean (i.e., horizontal 645 lines within boxes), shaded areas surrounding boxes represent 1 SD above and below mean 646 values